title: Phacilitate Immunotherapy Leaders' Forum: How to tap into dilutive and non-dilutive funding sources for immunotherapy projects--Barcelona, May 9-11, 2012.
abstract: How to tap into dilutive and non-dilutive funding sources for immunotherapy projects.
authors.affiliation: BB Biotech Ventures, Zürich, Switzerland. kb@bellevue.ch
authors.forename: Klaus
authors.initials: K
authors.lastname: Breiner
mesh_terms: D019496:Cancer Vaccines / Q000191:economics; D002202:Capital Financing; D003226:Congresses as Topic; D007167:Immunotherapy / Q000191:economics*
chemical_list: D019496:Cancer Vaccines
keywords: antibody-like drugs; biotech companies; cancer vaccines; funding; therapeutic antibodies; venture capital